In a successful week for the medical technology companies in the LSI Alumni community, we saw LSI Alumni secure new funding, receive a CE marking, enter new strategic partnerships, announce promising clinical trial results, and much more on the road to LSI USA ‘25 in Dana Point, CA (March 17-21).
Received Stage 2 funding through the ANDHealth+ program. The company develops the AtmoⓇ Gas Capsule System, a unique ingestible capsule designed to provide insights into gut health and microbiome function.
Received a CE marking for the expanded use of its flagship product, EndorailⓇ. EndorailⓇ is a magnetic balloon anchoring technology that anchors and guides endoscopes through the loops of the GI tract.
Announced the completion of the second phase of its clinical trial. The trial investigated CartReviveⓇ, a hydrogel implant designed to enable optimal cartilage repair in the knee.
Won a $100K prize in a pitch competition for regenerative medicine companies. The funds will help the company advance FDA approval of its OmegaSkin™ patches for wound closure and management.
Shared promising interim results from its first-in-human proof-of-concept trial with NVD-X3. NVD-X3 is an off-the-shelf, allogeneic matrix product designed to treat common orthopedic conditions.
Announced a strategic partnership with Barco, a global leader in healthcare display and imaging solutions. NZ Technologies develops touch-free Human-Machine Interaction products for the medical industry.
Launched a multi-site first-in-human study for the AccuroⓇ XV musculoskeletal imaging system. AccuroⓇ VX utilizes ultrasound-based bone and 3D soft-tissue imaging technology with AI-enabled software.
Announced the publication of new data demonstrating the accuracy and feasibility of EchoMark and EchoSure for AV fistula maturation assessment. The EchoMark/EchoSure System is a two-part system comprised of a bioresorbable implant, EchoMark, and a diagnostic ultrasound imaging platform, EchoSure.
Secured a patent in the Philippines, expanding its global reach. The company develops SurgiField™, an ultraportable, battery-powered sterile environment.
Completed the first revision total knee arthroplasties using its Universal™ Cone System. The Universal™ Cone System is a bone-conserving solution providing stable metaphyseal fixation in the femur and tibia.
Appointed Dr. Ian T. Meredith to its Board of Directors in preparation for its Series B2 closing. Dr. Meredith is the former Boston Scientific Executive Vice President and Global Chief Medical Officer.
Successfully demonstrated Continuous Anatomic Auto Tracking for robot-assisted total knee arthroplasty. This new capability is intended to enable VISIE’s 3D scanners to continuously track the two primary bones of the knee joint as they move.
Successfully completed the first U.S. implant using its Pro-X1Ⓡ Trochanteric Nailing System. The Pro-X1Ⓡ System features an expanding bolt design and offers stronger anchorage and rotational stability in osteoporotic hip fracture fixation than traditional screw-based approaches.
Stay tuned for more updates, insights, and achievements of our LSI Alumni in The Weekly Recap, and follow our blog for the latest medical device news and advancements.
Schedule an exploratory call
Request Info© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy
.png)
